176 related articles for article (PubMed ID: 11245426)
1. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
Sanchez-Cespedes M; Ahrendt SA; Piantadosi S; Rosell R; Monzo M; Wu L; Westra WH; Yang SC; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(4):1309-13. PubMed ID: 11245426
[TBL] [Abstract][Full Text] [Related]
2. Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance.
Wong MP; Lam WK; Wang E; Chiu SW; Lam CL; Chung LP
Cancer Res; 2002 Aug; 62(15):4464-8. PubMed ID: 12154056
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
[TBL] [Abstract][Full Text] [Related]
4. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers.
Wong MP; Fung LF; Wang E; Chow WS; Chiu SW; Lam WK; Ho KK; Ma ES; Wan TS; Chung LP
Cancer; 2003 Mar; 97(5):1263-70. PubMed ID: 12599234
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
7. p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
[TBL] [Abstract][Full Text] [Related]
8. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
Dacic S; Finkelstein SD; Yousem SA
Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
[TBL] [Abstract][Full Text] [Related]
9. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
10. Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers.
Powell CA; Bueno R; Borczuk AC; Caracta CF; Richards WG; Sugarbaker DJ; Brody JS
Lung Cancer; 2003 Jan; 39(1):23-9. PubMed ID: 12499090
[TBL] [Abstract][Full Text] [Related]
11. [Chromosomal imbalance in primary lung squamous cell carcinoma and their relationship with smoking].
Yan WS; Song LY; Wei WD; Li A; Liang QW; Liu JH; Fang Y
Ai Zheng; 2005 Jan; 24(1):47-52. PubMed ID: 15642199
[TBL] [Abstract][Full Text] [Related]
12. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.
Wistuba II; Behrens C; Virmani AK; Milchgrub S; Syed S; Lam S; Mackay B; Minna JD; Gazdar AF
Cancer Res; 1999 Apr; 59(8):1973-9. PubMed ID: 10213509
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
[TBL] [Abstract][Full Text] [Related]
14. Evidence for common clonal origin of multifocal lung cancers.
Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
[TBL] [Abstract][Full Text] [Related]
15. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.
Toyooka S; Tokumo M; Shigematsu H; Matsuo K; Asano H; Tomii K; Ichihara S; Suzuki M; Aoe M; Date H; Gazdar AF; Shimizu N
Cancer Res; 2006 Feb; 66(3):1371-5. PubMed ID: 16452191
[TBL] [Abstract][Full Text] [Related]
16. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
17. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
[TBL] [Abstract][Full Text] [Related]
20. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
